Free Trial
$100 Off. Every Year. Lock In MarketBeat All Access at $149
Claim the Rate Lock
Claim MarketBeat All Access Sale Promotion

FactSet Research Systems (FDS) Financials

FactSet Research Systems logo
$336.29 +16.38 (+5.12%)
Closing price 03:59 PM Eastern
Extended Trading
$332.94 -3.35 (-1.00%)
As of 05:03 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for FactSet Research Systems

Annual Income Statements for FactSet Research Systems

This table shows FactSet Research Systems' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 8/31/2016 8/31/2017 8/31/2018 8/31/2019 8/31/2020 8/31/2021 8/31/2022 8/31/2023 8/31/2024 8/31/2025 8/31/2026
Total Costs & Expenses
- - - - - - - - 1,502 1,573 1,776
Net Income / (Loss) Attributable to Common Shareholders
339 258 267 353 373 400 397 468 537 597 533
Consolidated Net Income / (Loss)
339 258 267 353 373 400 397 468 537 597 533
Net Income / (Loss) Continuing Operations
339 258 267 353 373 400 397 468 537 597 533
Total Pre-Tax Income
461 344 352 422 427 468 444 584 652 721 650
Total Operating Income
350 352 366 438 440 474 475 629 701 748 700
Total Gross Profit
640 655 691 772 799 805 973 1,112 1,191 1,224 1,253
Total Revenue
1,127 1,221 1,350 1,435 1,494 1,591 1,844 2,086 2,203 2,322 2,476
Operating Revenue
1,127 1,221 1,350 1,435 1,494 1,591 1,844 2,086 2,203 2,322 2,476
Total Cost of Revenue
487 567 659 663 695 786 871 973 1,012 1,098 1,223
Operating Cost of Revenue
487 567 659 663 695 786 871 973 1,012 1,098 1,223
Total Operating Expenses
290 302 325 334 359 331 497 483 490 476 553
Selling, General & Admin Expense
290 302 325 334 343 331 433 483 490 476 553
Total Other Income / (Expense), net
111 -7.82 -14 -16 -13 -6.39 -32 -45 -50 -27 -50
Interest Expense
- - - - - - 36 66 66 56 55
Interest & Investment Income
-1.14 -6.60 1.92 0.55 -9.83 -6.39 6.18 13 14 6.53 4.06
Other Income / (Expense), net
112 -1.22 -16 -17 -2.70 - -2.37 8.26 1.54 22 0.38
Income Tax Expense
122 86 85 69 54 68 47 116 114 124 116
Basic Earnings per Share
$8.29 $6.55 $6.90 $9.25 $9.83 $10.56 $10.48 $12.26 $14.11 $15.74 $14.63
Weighted Average Basic Shares Outstanding
40.88M 39.44M 38.73M 38.14M 37.94M 37.86M 37.86M 38.19M 38.06M 37.92M 36.47M
Diluted Earnings per Share
$8.19 $6.51 $6.78 $9.08 $9.65 $10.36 $10.25 $12.04 $13.91 $15.55 $14.57
Weighted Average Diluted Shares Outstanding
41.37M 39.64M 39.38M 38.87M 38.65M 38.57M 38.74M 38.90M 38.62M 38.39M 36.61M
Weighted Average Basic & Diluted Shares Outstanding
40.90M 39.40M 38.70M 37.94M 37.99M 37.64M 38.08M 37.99M 37.99M 37.46M 35.26M

Quarterly Income Statements for FactSet Research Systems

This table shows FactSet Research Systems' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026
Period end date 2/29/2024 5/31/2024 8/31/2024 11/30/2024 2/28/2025 5/31/2025 8/31/2025 11/30/2025 2/28/2026 5/31/2026 8/31/2026
Total Costs & Expenses
- - - - - - - - - - 478
Net Income / (Loss) Attributable to Common Shareholders
141 158 89 150 145 149 154 153 133 127 121
Consolidated Net Income / (Loss)
141 158 89 150 145 149 154 153 133 127 121
Net Income / (Loss) Continuing Operations
141 158 89 150 145 149 154 153 133 127 121
Total Pre-Tax Income
169 191 117 180 172 180 189 190 161 154 144
Total Operating Income
182 202 128 191 185 194 177 192 185 166 157
Total Gross Profit
291 306 304 310 301 305 308 320 314 311 308
Total Revenue
546 553 562 569 571 586 597 608 611 623 635
Operating Revenue
546 553 562 569 571 586 597 608 611 623 635
Total Cost of Revenue
255 247 258 259 270 281 289 288 297 312 326
Operating Cost of Revenue
255 247 258 259 270 281 289 288 297 312 326
Total Operating Expenses
109 103 176 119 116 111 131 128 129 144 152
Selling, General & Admin Expense
109 103 173 119 116 111 131 128 129 144 152
Total Other Income / (Expense), net
-13 -12 -11 -12 -13 -14 12 -1.96 -24 -12 -12
Interest Expense
17 17 16 14 14 15 13 13 13 14 14
Interest & Investment Income
2.85 4.57 4.02 2.70 0.27 1.51 2.05 1.09 0.89 0.64 1.44
Other Income / (Expense), net
0.46 0.40 0.80 0.10 0.47 -0.59 22 10 -12 1.02 0.70
Income Tax Expense
28 32 28 30 27 31 35 38 28 27 23
Basic Earnings per Share
$3.70 $4.15 $2.35 $3.95 $3.81 $3.92 $4.06 $4.08 $3.60 $3.51 $3.44
Weighted Average Basic Shares Outstanding
38.10M 38.09M 38.06M 38.01M 38.02M 37.91M 37.92M 37.41M 36.93M 36.12M 36.47M
Diluted Earnings per Share
$3.65 $4.09 $2.33 $3.89 $3.76 $3.87 $4.03 $4.06 $3.59 $3.50 $3.42
Weighted Average Diluted Shares Outstanding
38.65M 38.64M 38.62M 38.52M 38.51M 38.34M 38.39M 37.62M 37.06M 36.19M 36.61M
Weighted Average Basic & Diluted Shares Outstanding
38.12M 38.04M 37.99M 38.03M 37.95M 37.81M 37.46M 37.10M 36.43M 35.57M 35.26M

Annual Cash Flow Statements for FactSet Research Systems

This table details how cash moves in and out of FactSet Research Systems' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 8/31/2016 8/31/2017 8/31/2018 8/31/2019 8/31/2020 8/31/2021 8/31/2022 8/31/2023 8/31/2024 8/31/2025 8/31/2026
Net Change in Cash & Equivalents
69 -34 17 151 226 96 -179 -78 -2.47 -71 -112
Net Cash From Operating Activities
331 321 386 427 506 555 538 646 700 726 822
Net Cash From Continuing Operating Activities
331 321 386 427 506 555 538 646 700 726 822
Net Income / (Loss) Continuing Operations
339 258 267 353 373 400 397 468 537 597 533
Consolidated Net Income / (Loss)
339 258 267 353 373 400 397 468 537 597 533
Depreciation Expense
38 48 57 60 58 64 87 105 125 158 181
Amortization Expense
- - 0.00 0.00 43 43 43 32 30 31 32
Non-Cash Adjustments To Reconcile Net Income
-101 25 32 32 64 2.32 72 100 78 50 102
Changes in Operating Assets and Liabilities, net
55 -11 30 -19 -32 46 -60 -60 -70 -109 -26
Net Cash From Investing Activities
-158 -347 -49 -56 -74 -136 -2,034 -95 -144 -393 -133
Net Cash From Continuing Investing Activities
-158 -347 -49 -56 -74 -136 -2,034 -95 -144 -393 -133
Purchase of Property, Plant & Equipment
-48 -37 -34 -59 -78 -61 -51 -61 -86 -109 -115
Acquisitions
-263 -303 -15 0.00 0.00 -58 -1,982 -24 0.00 -348 0.00
Purchase of Investments
-18 -31 -12 -11 -2.74 -19 -0.88 -11 -59 -19 -54
Divestitures
153 - - - - - - 0.00 0.00 25 0.00
Sale and/or Maturity of Investments
17 23 12 14 6.75 2.18 - 0.00 0.00 58 36
Net Cash From Financing Activities
-91 -8.16 -320 -214 -218 -323 1,339 -632 -561 -408 -799
Net Cash From Continuing Financing Activities
-91 -8.16 -320 -214 -218 -323 1,339 -632 -561 -408 -799
Repayment of Debt
-0.01 -367 0.00 -576 -3.53 -4.26 -841 -389 -267 -822 -250
Repurchase of Common Equity
-357 -261 -304 -220 -200 -265 -19 -177 -235 -300 -644
Payment of Dividends
-74 -81 -89 -100 -110 -118 -126 -139 -151 -160 -164
Issuance of Debt
265 640 1.72 575 0.00 0.00 2,238 0.00 0.00 803 241
Issuance of Common Equity
57 50 72 107 96 64 86 72 92 82 33
Other Financing Activities, net
18 10 0.00 - - - - - 0.00 -10 -15
Effect of Exchange Rate Changes
-12 1.26 - -5.59 12 -0.26 -22 4.02 2.36 3.05 -2.31
Cash Interest Paid
3.01 8.47 16 20 13 8.02 30 77 66 55 52
Cash Income Taxes Paid
88 75 69 90 69 47 76 91 157 103 123

Quarterly Cash Flow Statements for FactSet Research Systems

This table details how cash moves in and out of FactSet Research Systems' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026
Period end date 2/29/2024 5/31/2024 8/31/2024 11/30/2024 2/28/2025 5/31/2025 8/31/2025 11/30/2025 2/28/2026 5/31/2026 8/31/2026
Net Change in Cash & Equivalents
-30 71 -30 -134 2.42 79 -19 -67 -7.11 17 -55
Net Cash From Operating Activities
144 238 163 86 174 254 212 121 212 285 205
Net Cash From Continuing Operating Activities
144 238 163 86 174 254 212 121 212 285 205
Net Income / (Loss) Continuing Operations
141 158 89 150 145 149 154 153 133 127 121
Consolidated Net Income / (Loss)
141 158 89 150 145 149 154 153 133 127 121
Depreciation Expense
32 33 34 36 38 41 43 44 44 46 47
Amortization Expense
7.65 7.58 7.56 7.57 7.61 7.98 7.83 8.00 8.19 8.08 8.00
Non-Cash Adjustments To Reconcile Net Income
6.65 4.06 13 14 29 21 -4.72 13 35 28 26
Changes in Operating Assets and Liabilities, net
-43 36 19 -121 -46 35 13 -96 -8.40 76 2.92
Net Cash From Investing Activities
-58 -21 -40 -145 -193 -31 -23 4.33 -26 -47 -63
Net Cash From Continuing Investing Activities
-58 -21 -40 -145 -193 -31 -23 4.33 -26 -47 -63
Purchase of Property, Plant & Equipment
-22 -21 -26 -26 -24 -25 -34 -31 -26 -30 -27
Purchase of Investments
-36 - -14 -3.99 -0.22 -0.23 -14 -0.88 -0.23 -17 -36
Net Cash From Financing Activities
-115 -144 -158 -70 25 -154 -208 -191 -196 -217 -196
Net Cash From Continuing Financing Activities
-115 -144 -158 -70 25 -154 -208 -191 -196 -217 -196
Repayment of Debt
-63 -64 -63 -76 -143 -544 -69 -5.70 -0.26 -75 -169
Repurchase of Common Equity
-52 -60 -63 -49 -64 -81 -107 -140 -163 -203 -138
Payment of Dividends
-37 -37 -39 -39 -40 -40 -42 -41 -41 -40 -42
Issuance of Debt
- - - 55 250 498 - 0.00 - 95 146
Issuance of Common Equity
38 17 8.21 39 21 12 9.07 8.55 8.12 11 5.76
Other Financing Activities, net
- - - 0.00 - - - -12 - -4.12 0.85
Effect of Exchange Rate Changes
-1.18 -1.78 4.28 -5.05 -3.00 10 1.08 -2.27 3.57 -2.98 -0.63

Annual Balance Sheets for FactSet Research Systems

This table presents FactSet Research Systems' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 8/31/2016 8/31/2017 8/31/2018 8/31/2019 8/31/2020 8/31/2021 8/31/2022 8/31/2023 8/31/2024 8/31/2025 8/31/2026
Total Assets
1,019 1,413 1,419 1,560 2,083 2,225 4,014 3,963 4,055 4,304 4,140
Total Current Assets
369 409 431 584 842 934 870 770 836 730 652
Cash & Equivalents
228 195 209 360 586 682 503 425 423 338 233
Short-Term Investments
24 32 29 26 20 36 33 32 70 17 32
Accounts Receivable
98 148 157 146 155 151 204 238 228 271 299
Prepaid Expenses
16 24 30 37 44 51 91 51 60 70 77
Current Deferred & Refundable Income Taxes
3.16 9.74 6.27 15 38 14 39 24 55 34 11
Plant, Property, & Equipment, net
85 100 101 119 133 131 81 86 83 85 79
Total Noncurrent Assets
565 903 888 857 1,108 1,160 3,063 3,107 3,137 3,489 3,409
Goodwill
453 708 702 686 710 754 966 1,005 1,011 1,285 1,283
Intangible Assets
93 174 149 124 121 135 1,896 1,859 1,844 1,916 1,850
Noncurrent Deferred & Refundable Income Taxes
13 7.41 9.72 7.57 - 2.25 3.15 27 61 61 75
Other Noncurrent Operating Assets
5.78 15 28 39 278 269 198 216 220 227 202
Total Liabilities & Shareholders' Equity
1,019 1,413 1,419 1,560 2,083 2,225 4,014 3,963 4,055 4,304 4,140
Total Liabilities
502 854 894 888 1,187 1,209 2,683 2,343 2,143 2,118 2,138
Total Current Liabilities
158 201 221 219 276 316 438 484 667 521 1,090
Short-Term Debt
- - - - - - - 0.00 125 0.00 499
Accounts Payable
46 59 72 80 82 86 108 122 178 135 136
Dividends Payable
20 22 24 27 29 31 34 37 39 41 41
Current Deferred Revenue
33 47 50 48 54 63 152 152 160 168 181
Current Deferred & Payable Income Tax Liabilities
8.07 11 8.45 - - - 0.00 31 40 13 5.01
Current Employee Benefit Liabilities
51 61 66 64 82 104 115 113 93 131 192
Other Current Liabilities
- - - 0.00 29 32 29 29 31 33 34
Total Noncurrent Liabilities
344 652 672 669 911 893 2,245 1,859 1,476 1,597 1,049
Long-Term Debt
300 575 575 574 574 575 1,982 1,613 1,241 1,368 871
Noncurrent Deferred Revenue
8.78 15 30 36 37 39 41 34 42 45 26
Noncurrent Deferred & Payable Income Tax Liabilities
1.71 25 21 16 20 15 8.80 6.74 8.45 15 11
Other Noncurrent Operating Liabilities
33 37 47 42 280 265 212 205 184 168 141
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
517 560 526 672 896 1,016 1,331 1,620 1,912 2,186 2,002
Total Preferred & Common Equity
517 560 526 672 896 1,016 1,331 1,620 1,912 2,186 2,002
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
517 560 526 672 896 1,016 1,331 1,620 1,912 2,186 2,002
Common Stock
624 742 668 807 939 1,049 1,191 1,324 1,479 1,622 1,740
Retained Earnings
1,284 1,459 123 373 633 913 1,180 1,505 1,889 2,323 2,693
Treasury Stock
-1,322 -1,607 -213 -434 -637 -906 -931 -1,122 -1,376 -1,695 -2,352
Accumulated Other Comprehensive Income / (Loss)
-69 -35 -51 -75 -39 -39 -108 -87 -80 -64 -78

Quarterly Balance Sheets for FactSet Research Systems

This table presents FactSet Research Systems' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 8/31/2023 11/30/2023 2/29/2024 5/31/2024 8/31/2024 11/30/2024 2/28/2025 5/31/2025 11/30/2025 2/28/2026 5/31/2026
Total Assets
3,963 3,951 3,991 4,040 4,055 4,049 4,241 4,339 4,221 4,220 4,192
Total Current Assets
770 766 823 858 836 751 708 760 709 724 728
Cash & Equivalents
425 412 382 453 423 289 279 356 275 268 288
Short-Term Investments
32 32 69 69 70 70 8.47 7.68 17 17 16
Accounts Receivable
238 245 272 240 228 253 278 272 289 320 290
Prepaid Expenses
51 51 58 52 60 61 67 64 101 90 75
Current Deferred & Refundable Income Taxes
24 26 43 44 55 79 76 61 26 29 58
Plant, Property, & Equipment, net
86 83 81 81 83 82 80 80 85 84 82
Total Noncurrent Assets
3,107 3,102 3,087 3,101 3,137 3,216 3,454 3,499 3,427 3,411 3,382
Goodwill
1,005 1,005 1,004 1,005 1,011 1,092 1,245 1,278 1,280 1,287 1,283
Intangible Assets
1,859 1,848 1,861 1,851 1,844 1,870 1,935 1,931 1,900 1,885 1,868
Noncurrent Deferred & Refundable Income Taxes
27 24 24 37 61 40 54 67 60 61 42
Other Noncurrent Operating Assets
216 225 198 208 220 214 220 223 188 178 188
Total Liabilities & Shareholders' Equity
3,963 3,951 3,991 4,040 4,055 4,049 4,241 4,339 4,221 4,220 4,192
Total Liabilities
2,343 2,250 2,189 2,149 2,143 2,057 2,185 2,184 2,053 2,091 2,160
Total Current Liabilities
484 456 460 672 667 538 482 519 459 506 1,065
Short-Term Debt
0.00 - 29 187 125 62 0.00 0.00 - - 499
Accounts Payable
122 150 128 138 178 151 131 144 149 149 164
Dividends Payable
37 37 37 40 39 40 40 42 41 40 42
Current Deferred Revenue
152 150 175 168 160 157 177 171 163 189 183
Current Deferred & Payable Income Tax Liabilities
31 37 18 29 40 45 30 31 14 5.61 5.18
Current Employee Benefit Liabilities
113 52 72 79 93 52 71 98 60 88 137
Other Current Liabilities
29 29 - 30 31 31 33 33 33 34 34
Total Noncurrent Liabilities
1,859 1,795 1,729 1,478 1,476 1,519 1,703 1,665 1,594 1,585 1,095
Long-Term Debt
1,613 1,551 1,489 1,241 1,241 1,297 1,472 1,430 1,369 1,369 891
Noncurrent Deferred Revenue
34 35 39 39 42 43 47 48 45 41 41
Noncurrent Deferred & Payable Income Tax Liabilities
6.74 9.33 8.23 7.94 8.45 15 15 17 15 15 13
Other Noncurrent Operating Liabilities
205 199 6.97 191 184 164 169 170 166 159 150
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
1,620 1,701 1,802 1,890 1,912 1,992 2,057 2,155 2,168 2,129 2,032
Total Preferred & Common Equity
1,620 1,701 1,802 1,890 1,912 1,992 2,057 2,155 2,168 2,129 2,032
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
1,620 1,701 1,802 1,890 1,912 1,992 2,057 2,155 2,168 2,129 2,032
Common Stock
1,324 1,367 1,422 1,454 1,479 1,532 1,570 1,599 1,649 1,678 1,711
Retained Earnings
1,505 1,616 1,720 1,838 1,889 1,999 2,104 2,211 2,435 2,528 2,613
Treasury Stock
-1,122 -1,195 -1,249 -1,310 -1,376 -1,439 -1,504 -1,586 -1,842 -2,007 -2,213
Accumulated Other Comprehensive Income / (Loss)
-87 -87 -91 -93 -80 -100 -113 -69 -74 -70 -79

Annual Metrics And Ratios for FactSet Research Systems

This table displays calculated financial ratios and metrics derived from FactSet Research Systems' official financial filings.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 8/31/2016 8/31/2017 8/31/2018 8/31/2019 8/31/2020 8/31/2021 8/31/2022 8/31/2023 8/31/2024 8/31/2025 8/31/2026
DEI Shares Outstanding
- - - - - - - - - - 35,565,543.00
DEI Adjusted Shares Outstanding
- - - - - - - - - - 35,565,543.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - - 15.00
Growth Metrics
- - - - - - - - - - -
Revenue Growth
11.95% 8.35% 10.56% 6.31% 4.09% 6.51% 15.86% 13.10% 5.64% 5.39% 6.65%
EBITDA Growth
37.69% -20.19% 2.00% 18.34% 11.60% 8.11% 3.69% 28.59% 10.74% 11.77% -4.79%
EBIT Growth
39.23% -24.07% -0.28% 20.43% 3.69% 8.49% -0.20% 34.74% 10.25% 9.66% -9.14%
NOPAT Growth
7.21% 2.77% 5.25% 31.74% 4.82% 5.52% 5.03% 18.57% 14.62% 7.18% -7.25%
Net Income Growth
40.56% -23.78% 3.42% 32.09% 5.71% 7.15% -0.67% 17.95% 14.73% 11.15% -10.65%
EPS Growth
43.43% -20.51% 4.15% 33.92% 6.28% 7.36% -1.06% 17.46% 15.53% 11.79% -6.30%
Operating Cash Flow Growth
8.06% -3.21% 20.32% 10.75% 18.43% 9.76% -3.05% 19.93% 8.48% 3.70% 13.21%
Free Cash Flow Firm Growth
-67.34% -207.90% 497.83% 14.08% 3.31% 4.96% -474.18% 133.97% 12.26% -63.90% 227.58%
Invested Capital Growth
45.34% 58.93% -4.53% 0.12% 0.74% 1.01% 211.01% 0.04% 0.46% 14.71% -2.89%
Revenue Q/Q Growth
2.32% 3.33% 1.44% 1.30% 1.31% 1.81% 4.98% 1.78% 1.21% 1.52% 1.55%
EBITDA Q/Q Growth
31.37% -22.11% -2.50% 1.83% 5.34% 3.95% 3.50% -1.86% 2.52% 9.11% -3.98%
EBIT Q/Q Growth
33.80% -25.17% -2.88% 1.59% -3.47% 4.92% 2.31% -1.22% 1.34% 10.17% -5.72%
NOPAT Q/Q Growth
0.01% 0.03% 4.05% 6.35% -0.76% 2.64% 4.17% -8.64% 4.93% 8.01% -2.17%
Net Income Q/Q Growth
31.99% -24.71% 3.60% 6.88% -0.65% 3.09% 0.85% -7.74% 4.75% 12.03% -5.74%
EPS Q/Q Growth
32.95% -23.50% 3.99% 6.82% -0.62% 3.29% 0.69% -7.74% 4.90% 12.27% -4.02%
Operating Cash Flow Q/Q Growth
-3.94% 10.39% 1.61% 3.76% 8.03% 4.82% -5.88% 0.67% 1.08% 7.23% -0.89%
Free Cash Flow Firm Q/Q Growth
78.82% -64.95% 4.31% 10.75% 0.24% 12.91% -0.29% -6.19% -2.05% 39.27% -3.32%
Invested Capital Q/Q Growth
-5.38% -0.16% -0.43% -1.93% -2.33% -5.85% -1.23% -1.73% -0.37% -0.67% -0.37%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
56.76% 53.60% 51.17% 53.78% 53.45% 50.59% 52.76% 53.33% 54.07% 52.72% 50.61%
EBITDA Margin
44.38% 32.69% 30.16% 33.57% 35.99% 36.53% 32.69% 37.17% 38.97% 41.32% 36.89%
Operating Margin
31.02% 28.84% 27.12% 30.52% 29.43% 29.79% 25.79% 30.17% 31.83% 32.23% 28.27%
EBIT Margin
41.00% 28.74% 25.92% 29.36% 29.25% 29.79% 25.66% 30.57% 31.90% 33.20% 28.28%
Profit (Net Income) Margin
30.06% 21.15% 19.78% 24.58% 24.96% 25.11% 21.53% 22.45% 24.38% 25.72% 21.54%
Tax Burden Percent
73.50% 75.01% 75.91% 83.61% 87.31% 85.45% 89.48% 80.17% 82.44% 82.81% 82.11%
Interest Burden Percent
99.75% 98.12% 100.55% 100.13% 97.75% 98.64% 93.76% 91.61% 92.70% 93.54% 92.77%
Effective Tax Rate
26.50% 24.99% 24.09% 16.39% 12.69% 14.55% 10.52% 19.83% 17.56% 17.19% 17.89%
Return on Invested Capital (ROIC)
52.07% 34.89% 30.61% 41.25% 43.06% 45.04% 22.90% 17.94% 20.51% 20.43% 17.99%
ROIC Less NNEP Spread (ROIC-NNEP)
-212.54% 32.20% 27.62% 36.60% 32.86% 54.67% 18.73% 15.23% 16.61% 18.13% 14.24%
Return on Net Nonoperating Assets (RNNOA)
12.53% 13.07% 18.60% 17.64% 4.49% -3.26% 10.91% 13.79% 9.90% 8.70% 7.48%
Return on Equity (ROE)
64.60% 47.96% 49.21% 58.89% 47.55% 41.78% 33.81% 31.73% 30.41% 29.13% 25.48%
Cash Return on Invested Capital (CROIC)
15.11% -10.63% 35.24% 41.14% 42.32% 44.03% -79.78% 17.90% 20.05% 6.73% 20.92%
Operating Return on Assets (OROA)
52.64% 28.85% 24.71% 28.29% 23.99% 22.01% 15.17% 15.98% 17.53% 18.44% 16.59%
Return on Assets (ROA)
38.59% 21.23% 18.86% 23.68% 20.47% 18.55% 12.72% 11.74% 13.40% 14.28% 12.64%
Return on Common Equity (ROCE)
64.60% 47.96% 49.21% 58.89% 47.55% 41.78% 33.81% 31.73% 30.41% 29.13% 25.48%
Return on Equity Simple (ROE_SIMPLE)
65.49% 46.14% 50.79% 52.48% 41.61% 39.32% 29.81% 28.90% 28.09% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
257 264 278 366 384 405 425 504 578 620 575
NOPAT Margin
22.80% 21.63% 20.59% 25.51% 25.69% 25.45% 23.07% 24.19% 26.24% 26.69% 23.21%
Net Nonoperating Expense Percent (NNEP)
264.61% 2.69% 2.98% 4.65% 10.20% -9.63% 4.17% 2.72% 3.90% 2.30% 3.75%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - - - 17.43% 17.04%
Cost of Revenue to Revenue
43.24% 46.40% 48.83% 46.22% 46.55% 49.41% 47.24% 46.67% 45.93% 47.28% 49.40%
SG&A Expenses to Revenue
25.73% 24.77% 24.05% 23.26% 22.92% 20.80% 23.48% 21.92% 22.02% 20.49% 22.34%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
25.73% 24.77% 24.05% 23.26% 24.03% 20.80% 26.97% 23.16% 22.23% 20.49% 22.34%
Earnings before Interest and Taxes (EBIT)
462 351 350 421 437 474 473 637 703 771 700
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
500 399 407 482 538 581 603 775 858 959 913
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
12.93 10.31 15.85 14.82 14.36 13.80 12.14 10.18 8.41 6.46 5.57
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 196.31 110.29 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
5.94 4.73 6.17 6.94 8.62 8.81 8.76 7.91 7.30 6.08 4.50
Price to Earnings (P/E)
19.74 22.35 31.20 28.25 34.52 35.10 40.72 35.23 29.95 23.64 20.90
Dividend Yield
1.14% 1.44% 1.10% 1.04% 0.88% 0.86% 0.80% 0.87% 0.96% 1.15% 1.44%
Earnings Yield
5.06% 4.47% 3.20% 3.54% 2.90% 2.85% 2.46% 2.84% 3.34% 4.23% 4.78%
Enterprise Value to Invested Capital (EV/IC)
11.52 6.59 9.77 11.43 14.35 15.36 6.26 6.28 6.00 4.67 3.89
Enterprise Value to Revenue (EV/Rev)
5.98 5.01 6.42 7.07 8.60 8.72 9.55 8.46 7.70 6.52 4.95
Enterprise Value to EBITDA (EV/EBITDA)
13.47 15.33 21.29 21.07 23.88 23.88 29.21 22.77 19.76 15.77 13.42
Enterprise Value to EBIT (EV/EBIT)
14.58 17.44 24.78 24.10 29.39 29.28 37.21 27.68 24.13 19.63 17.50
Enterprise Value to NOPAT (EV/NOPAT)
26.21 23.17 31.19 27.73 33.45 34.27 41.38 34.98 29.33 24.41 21.33
Enterprise Value to Operating Cash Flow (EV/OCF)
20.34 19.10 22.48 23.77 25.39 25.00 32.71 27.34 24.21 20.83 14.91
Enterprise Value to Free Cash Flow (EV/FCFF)
90.33 0.00 27.09 27.80 34.04 35.05 0.00 35.06 30.01 74.15 18.34
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.58 1.03 1.09 0.85 0.64 0.57 1.49 1.00 0.71 0.63 0.68
Long-Term Debt to Equity
0.58 1.03 1.09 0.85 0.64 0.57 1.49 1.00 0.65 0.63 0.43
Financial Leverage
-0.06 0.41 0.67 0.48 0.14 -0.06 0.58 0.91 0.60 0.48 0.53
Leverage Ratio
1.67 2.26 2.61 2.49 2.32 2.25 2.66 2.70 2.27 2.04 2.02
Compound Leverage Factor
1.67 2.22 2.62 2.49 2.27 2.22 2.49 2.48 2.10 1.91 1.87
Debt to Total Capital
36.70% 50.67% 52.22% 46.07% 39.05% 36.11% 59.82% 49.89% 41.67% 38.49% 40.63%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 3.81% 0.00% 14.81%
Long-Term Debt to Total Capital
36.70% 50.67% 52.22% 46.07% 39.05% 36.11% 59.82% 49.89% 37.86% 38.49% 25.82%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
63.30% 49.33% 47.78% 53.93% 60.95% 63.89% 40.18% 50.11% 58.33% 61.51% 59.37%
Debt to EBITDA
0.60 1.44 1.41 1.19 1.07 0.99 3.29 2.08 1.59 1.43 1.50
Net Debt to EBITDA
0.09 0.87 0.83 0.39 -0.06 -0.25 2.40 1.49 1.02 1.06 1.21
Long-Term Debt to EBITDA
0.60 1.44 1.41 1.19 1.07 0.99 3.29 2.08 1.45 1.43 0.95
Debt to NOPAT
1.17 2.18 2.07 1.57 1.50 1.42 4.66 3.20 2.36 2.21 2.38
Net Debt to NOPAT
0.18 1.32 1.21 0.51 -0.08 -0.35 3.40 2.29 1.51 1.64 1.92
Long-Term Debt to NOPAT
1.17 2.18 2.07 1.57 1.50 1.42 4.66 3.20 2.15 2.21 1.51
Altman Z-Score
12.61 7.36 7.66 9.16 8.67 9.29 5.00 5.90 6.32 5.94 5.07
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
2.33 2.04 1.95 2.67 3.05 2.96 1.99 1.59 1.25 1.40 0.60
Quick Ratio
2.21 1.87 1.78 2.43 2.75 2.75 1.69 1.44 1.08 1.20 0.52
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
75 -80 320 365 377 396 -1,482 503 565 204 668
Operating Cash Flow to CapEx
693.63% 869.53% 1,150.56% 719.45% 651.50% 905.38% 1,052.23% 1,062.04% 817.38% 667.48% 716.70%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 -41.51 7.59 8.59 3.62 12.22
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 15.08 9.73 10.65 12.89 15.04
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 13.65 8.82 9.34 10.96 12.94
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
1.28 1.00 0.95 0.96 0.82 0.74 0.59 0.52 0.55 0.56 0.59
Accounts Receivable Turnover
11.69 9.92 8.85 9.48 9.92 10.39 10.38 9.44 9.46 9.31 8.70
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
15.67 13.20 13.43 13.05 11.84 12.03 17.38 24.98 26.13 27.69 30.12
Accounts Payable Turnover
12.23 10.79 10.04 8.75 8.60 9.37 8.97 8.46 6.74 7.00 9.01
Days Sales Outstanding (DSO)
31.23 36.78 41.22 38.52 36.81 35.11 35.16 38.66 38.58 39.20 41.96
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
29.85 33.84 36.34 41.72 42.44 38.96 40.68 43.17 54.12 52.12 40.49
Cash Conversion Cycle (CCC)
1.38 2.95 4.89 -3.20 -5.63 -3.84 -5.51 -4.51 -15.54 -12.92 1.47
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
585 929 887 888 895 904 2,811 2,812 2,825 3,241 3,147
Invested Capital Turnover
2.28 1.61 1.49 1.62 1.68 1.77 0.99 0.74 0.78 0.77 0.78
Increase / (Decrease) in Invested Capital
182 345 -42 1.03 6.57 9.05 1,907 1.04 13 416 -94
Enterprise Value (EV)
6,737 6,121 8,671 10,154 12,842 13,881 17,607 17,648 16,958 15,127 12,256
Market Capitalization
6,689 5,773 8,334 9,965 12,873 14,024 16,161 16,493 16,085 14,114 11,152
Book Value per Share
$12.73 $14.27 $13.71 $17.57 $23.59 $26.90 $35.06 $42.47 $50.28 $57.83 $56.29
Tangible Book Value per Share
($0.71) ($8.19) ($8.47) ($3.61) $1.73 $3.37 ($40.29) ($32.61) ($24.78) ($26.83) ($31.79)
Total Capital
817 1,135 1,101 1,246 1,471 1,591 3,314 3,233 3,278 3,555 3,372
Total Debt
300 575 575 574 574 575 1,982 1,613 1,366 1,368 1,370
Total Long-Term Debt
300 575 575 574 574 575 1,982 1,613 1,241 1,368 871
Net Debt
47 348 337 189 -31 -143 1,446 1,155 873 1,013 1,105
Capital Expenditures (CapEx)
48 37 34 59 78 61 51 61 86 109 115
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-42 -19 -28 -21 -40 -100 -104 -172 -199 -147 -204
Debt-free Net Working Capital (DFNWC)
211 208 210 365 566 618 432 286 294 208 62
Net Working Capital (NWC)
211 208 210 365 566 618 432 286 169 208 -438
Net Nonoperating Expense (NNE)
-82 5.87 11 13 11 5.49 29 36 41 23 41
Net Nonoperating Obligations (NNO)
67 370 361 216 -1.54 -112 1,480 1,192 913 1,055 1,146
Total Depreciation and Amortization (D&A)
38 48 57 60 101 107 130 138 156 189 213
Debt-free, Cash-free Net Working Capital to Revenue
-3.69% -1.55% -2.08% -1.44% -2.65% -6.28% -5.66% -8.24% -9.03% -6.32% -8.22%
Debt-free Net Working Capital to Revenue
18.73% 17.05% 15.54% 25.42% 37.86% 38.82% 23.43% 13.71% 13.33% 8.98% 2.50%
Net Working Capital to Revenue
18.73% 17.05% 15.54% 25.42% 37.86% 38.82% 23.43% 13.71% 7.66% 8.98% -17.67%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$8.29 $6.55 $6.90 $9.25 $9.83 $10.56 $10.48 $12.26 $14.11 $15.74 $14.63
Adjusted Weighted Average Basic Shares Outstanding
40.88M 39.44M 38.73M 38.14M 37.94M 37.86M 37.86M 38.19M 38.06M 37.92M 36.47M
Adjusted Diluted Earnings per Share
$8.19 $6.51 $6.78 $9.08 $9.65 $10.36 $10.25 $12.04 $13.91 $15.55 $14.57
Adjusted Weighted Average Diluted Shares Outstanding
41.37M 39.64M 39.38M 38.87M 38.65M 38.57M 38.74M 38.90M 38.62M 38.39M 36.61M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
39.94M 39.11M 38.04M 37.94M 37.99M 37.64M 38.08M 37.99M 37.99M 37.46M 35.26M
Normalized Net Operating Profit after Tax (NOPAT)
257 264 278 366 398 405 483 525 582 620 575
Normalized NOPAT Margin
22.80% 21.63% 20.59% 25.51% 26.66% 25.45% 26.19% 25.19% 26.42% 26.69% 23.21%
Pre Tax Income Margin
40.90% 28.20% 26.06% 29.40% 28.59% 29.38% 24.06% 28.00% 29.57% 31.05% 26.24%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 13.25 9.61 10.68 13.68 12.81
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 11.92 7.61 8.79 11.00 10.51
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 11.82 8.70 9.38 11.75 10.71
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 10.49 6.69 7.49 9.07 8.41
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
21.91% 31.32% 33.48% 28.36% 29.61% 29.51% 31.73% 29.60% 28.05% 26.79% 30.78%
Augmented Payout Ratio
127.22% 132.38% 147.28% 90.83% 83.14% 95.76% 36.42% 67.35% 71.85% 77.12% 151.49%

Quarterly Metrics And Ratios for FactSet Research Systems

This table displays calculated financial ratios and metrics derived from FactSet Research Systems' official financial filings.

Metric Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026
Period end date 2/29/2024 5/31/2024 8/31/2024 11/30/2024 2/28/2025 5/31/2025 8/31/2025 11/30/2025 2/28/2026 5/31/2026 8/31/2026
DEI Shares Outstanding
- - - - - - - - 37,099,259.00 36,431,127.00 35,565,543.00
DEI Adjusted Shares Outstanding
- - - - - - - - 37,099,259.00 36,431,127.00 35,565,543.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - 3.59 3.48 3.41
Growth Metrics
- - - - - - - - - - -
Revenue Growth
5.99% 4.32% 4.93% 4.88% 4.53% 5.94% 6.17% 6.85% 7.07% 6.39% 6.33%
EBITDA Growth
7.22% 14.93% 14.12% 4.97% 4.67% -0.23% 47.04% 8.45% -2.94% -8.71% -15.13%
EBIT Growth
6.92% 15.74% 7.77% 1.33% 1.96% -4.58% 55.29% 5.73% -6.82% -13.56% -21.25%
NOPAT Growth
7.02% 17.55% 38.66% -0.37% 2.55% -4.62% 47.57% -3.47% -2.04% -14.69% -8.85%
Net Income Growth
7.10% 17.43% 37.43% 0.99% 2.78% -6.07% 71.65% 1.71% -8.15% -14.69% -21.15%
EPS Growth
7.99% 18.21% 38.69% 1.30% 3.01% -5.38% 72.96% 4.37% -4.52% -9.56% -15.14%
Operating Cash Flow Growth
-12.68% 8.99% 4.81% -44.33% 20.97% 6.55% 29.99% 40.42% 21.69% 12.09% -3.49%
Free Cash Flow Firm Growth
97.62% 52.31% 21.92% -112.47% 21.65% -237.62% -420.84% -274.79% 656.13% 190.07% 182.84%
Invested Capital Growth
6.68% -0.91% 0.46% 6.54% 6.09% 15.07% 14.71% 8.36% -0.86% -3.18% -2.89%
Revenue Q/Q Growth
0.69% 1.24% 1.72% 1.15% 0.35% 2.60% 1.94% 1.80% 0.56% 1.95% 1.89%
EBITDA Q/Q Growth
-0.89% 9.62% -29.92% 37.87% -1.17% 4.48% 3.28% 1.68% -11.55% -1.73% -3.99%
EBIT Q/Q Growth
-3.45% 11.22% -36.58% 48.80% -2.86% 4.09% 3.22% 1.31% -14.39% -3.44% -5.97%
NOPAT Q/Q Growth
-5.14% 10.51% -41.86% 63.47% -2.36% 2.78% -10.05% 6.93% -0.91% -10.49% -3.89%
Net Income Q/Q Growth
-5.13% 12.20% -43.41% 67.63% -3.44% 2.54% 3.42% -0.67% -12.80% -4.76% -4.41%
EPS Q/Q Growth
-4.95% 12.05% -43.03% 66.95% -3.34% 2.93% 4.13% 0.74% -11.58% -2.51% -2.29%
Operating Cash Flow Q/Q Growth
-7.31% 65.67% -31.51% -47.06% 101.40% 45.92% -16.44% -42.82% 74.54% 34.41% -28.05%
Free Cash Flow Firm Q/Q Growth
-119.54% 567.10% -56.38% -131.31% -22.80% -720.49% -1.70% 63.42% 282.21% 32.88% -6.45%
Invested Capital Q/Q Growth
8.71% -8.32% -0.37% 7.30% 8.25% -0.57% -0.67% 1.36% -0.96% -2.89% -0.37%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
53.27% 55.31% 54.07% 54.49% 52.76% 52.05% 51.64% 52.62% 51.43% 49.88% 48.59%
EBITDA Margin
40.59% 43.96% 30.28% 41.28% 40.65% 41.40% 41.94% 41.89% 36.85% 35.52% 33.47%
Operating Margin
33.33% 36.63% 22.74% 33.65% 32.50% 33.16% 29.71% 31.61% 30.27% 26.70% 24.68%
EBIT Margin
33.41% 36.70% 22.89% 33.66% 32.59% 33.06% 33.47% 33.31% 28.36% 26.86% 24.79%
Profit (Net Income) Margin
25.82% 28.61% 15.92% 26.38% 25.38% 25.37% 25.74% 25.11% 21.78% 20.34% 19.08%
Tax Burden Percent
83.57% 83.00% 76.41% 83.47% 84.06% 82.55% 81.30% 80.26% 82.59% 82.22% 83.90%
Interest Burden Percent
92.46% 93.92% 91.04% 93.89% 92.66% 92.97% 94.58% 93.93% 92.98% 92.11% 91.76%
Effective Tax Rate
16.43% 17.00% 23.59% 16.53% 15.94% 17.45% 18.70% 19.74% 17.41% 17.78% 16.10%
Return on Invested Capital (ROIC)
20.02% 23.23% 13.58% 21.31% 19.33% 20.53% 18.49% 18.96% 18.37% 16.67% 16.05%
ROIC Less NNEP Spread (ROIC-NNEP)
19.16% 22.30% 12.80% 20.42% 18.45% 19.39% 19.45% 18.82% 16.69% 15.77% 15.12%
Return on Net Nonoperating Assets (RNNOA)
14.52% 13.40% 7.63% 12.08% 12.03% 9.84% 9.33% 9.76% 9.37% 8.42% 7.94%
Return on Equity (ROE)
34.54% 36.63% 21.21% 33.39% 31.35% 30.37% 27.82% 28.72% 27.74% 25.09% 23.99%
Cash Return on Invested Capital (CROIC)
11.09% 20.25% 20.05% 13.32% 12.33% 4.80% 6.73% 11.42% 19.56% 21.52% 20.92%
Operating Return on Assets (OROA)
18.01% 19.88% 12.58% 18.76% 17.85% 18.05% 18.59% 19.02% 16.10% 15.36% 14.54%
Return on Assets (ROA)
13.91% 15.50% 8.75% 14.70% 13.90% 13.85% 14.30% 14.34% 12.36% 11.63% 11.19%
Return on Common Equity (ROCE)
34.54% 36.63% 21.21% 33.39% 31.35% 30.37% 27.82% 28.72% 27.74% 25.09% 23.99%
Return on Equity Simple (ROE_SIMPLE)
27.16% 27.12% 0.00% 27.04% 26.38% 24.73% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
152 168 98 160 156 160 144 154 153 137 131
NOPAT Margin
27.85% 30.40% 17.38% 28.08% 27.33% 27.37% 24.15% 25.37% 25.00% 21.95% 20.70%
Net Nonoperating Expense Percent (NNEP)
0.86% 0.93% 0.78% 0.89% 0.88% 1.14% -0.96% 0.15% 1.68% 0.90% 0.93%
Return On Investment Capital (ROIC_SIMPLE)
- - - 4.77% 4.42% 4.47% 4.06% 4.36% 4.37% 4.00% 3.90%
Cost of Revenue to Revenue
46.73% 44.69% 45.93% 45.51% 47.24% 47.95% 48.36% 47.38% 48.57% 50.12% 51.41%
SG&A Expenses to Revenue
19.93% 18.65% 30.69% 20.85% 20.25% 18.90% 21.93% 21.01% 21.16% 23.19% 23.91%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
19.94% 18.68% 31.33% 20.85% 20.25% 18.90% 21.93% 21.01% 21.16% 23.19% 23.91%
Earnings before Interest and Taxes (EBIT)
182 203 129 191 186 194 200 202 173 167 157
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
222 243 170 235 232 242 250 255 225 221 212
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
9.75 8.15 8.41 9.36 8.54 8.07 6.46 4.79 3.78 4.40 5.57
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
8.16 7.08 7.30 8.36 7.79 7.60 6.08 4.40 3.35 3.67 4.50
Price to Earnings (P/E)
35.92 30.05 29.95 34.61 32.37 32.63 23.64 17.32 13.68 15.80 20.90
Dividend Yield
0.85% 0.98% 0.96% 0.84% 0.90% 0.92% 1.15% 1.57% 2.03% 1.82% 1.44%
Earnings Yield
2.78% 3.33% 3.34% 2.89% 3.09% 3.06% 4.23% 5.77% 7.31% 6.33% 4.78%
Enterprise Value to Invested Capital (EV/IC)
6.09 5.75 6.00 6.48 5.71 5.66 4.67 3.49 2.81 3.17 3.89
Enterprise Value to Revenue (EV/Rev)
8.74 7.50 7.70 8.81 8.32 8.07 6.52 4.86 3.80 4.11 4.95
Enterprise Value to EBITDA (EV/EBITDA)
23.36 19.48 19.76 22.59 21.30 20.99 15.77 11.70 9.39 10.54 13.42
Enterprise Value to EBIT (EV/EBIT)
28.27 23.52 24.13 27.84 26.44 26.38 19.63 14.66 11.87 13.50 17.50
Enterprise Value to NOPAT (EV/NOPAT)
35.80 29.61 29.33 34.00 32.24 32.17 24.41 18.66 14.94 17.07 21.33
Enterprise Value to Operating Cash Flow (EV/OCF)
27.97 23.55 24.21 31.10 28.33 27.25 20.83 15.06 11.42 12.09 14.91
Enterprise Value to Free Cash Flow (EV/FCFF)
56.65 28.28 30.01 50.18 47.69 126.00 74.15 31.78 14.28 14.51 18.34
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.95 0.76 0.71 0.68 0.72 0.66 0.63 0.63 0.64 0.68 0.68
Long-Term Debt to Equity
0.93 0.66 0.65 0.65 0.72 0.66 0.63 0.63 0.64 0.44 0.43
Financial Leverage
0.76 0.60 0.60 0.59 0.65 0.51 0.48 0.52 0.56 0.53 0.53
Leverage Ratio
2.34 2.26 2.27 2.17 2.13 2.07 2.04 1.99 2.02 2.04 2.02
Compound Leverage Factor
2.17 2.12 2.07 2.03 1.98 1.93 1.93 1.87 1.88 1.88 1.85
Debt to Total Capital
48.61% 43.03% 41.67% 40.56% 41.72% 39.89% 38.49% 38.70% 39.14% 40.61% 40.63%
Short-Term Debt to Total Capital
0.83% 5.64% 3.81% 1.86% 0.00% 0.00% 0.00% 0.00% 0.00% 14.59% 14.81%
Long-Term Debt to Total Capital
47.78% 37.39% 37.86% 38.70% 41.72% 39.89% 38.49% 38.70% 39.14% 26.02% 25.82%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
51.39% 56.97% 58.33% 59.44% 58.28% 60.11% 61.51% 61.30% 60.86% 59.39% 59.37%
Debt to EBITDA
2.11 1.71 1.59 1.56 1.67 1.63 1.43 1.40 1.41 1.46 1.50
Net Debt to EBITDA
1.56 1.08 1.02 1.15 1.35 1.21 1.06 1.10 1.11 1.14 1.21
Long-Term Debt to EBITDA
2.08 1.48 1.45 1.49 1.67 1.63 1.43 1.40 1.41 0.94 0.95
Debt to NOPAT
3.24 2.59 2.36 2.35 2.53 2.49 2.21 2.23 2.24 2.37 2.38
Net Debt to NOPAT
2.38 1.64 1.51 1.73 2.04 1.86 1.64 1.75 1.77 1.85 1.92
Long-Term Debt to NOPAT
3.19 2.25 2.15 2.24 2.53 2.49 2.21 2.23 2.24 1.52 1.51
Altman Z-Score
6.22 5.70 5.85 6.90 6.26 6.23 5.51 4.63 3.91 3.97 4.64
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.79 1.28 1.25 1.40 1.47 1.47 1.40 1.54 1.43 0.68 0.60
Quick Ratio
1.57 1.14 1.08 1.14 1.17 1.23 1.20 1.27 1.20 0.56 0.52
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-42 194 85 -26 -33 -267 -272 -99 181 240 225
Operating Cash Flow to CapEx
656.10% 1,116.43% 628.53% 333.82% 732.87% 1,006.08% 624.45% 393.18% 814.28% 933.62% 747.08%
Free Cash Flow to Firm to Interest Expense
-2.50 11.48 5.44 -1.84 -2.34 -17.66 -21.07 -7.42 13.85 17.38 15.62
Operating Cash Flow to Interest Expense
8.66 14.10 10.49 6.00 12.50 16.79 16.46 9.06 16.21 20.56 14.22
Operating Cash Flow Less CapEx to Interest Expense
7.34 12.84 8.83 4.20 10.79 15.12 13.82 6.76 14.22 18.36 12.31
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.54 0.54 0.55 0.56 0.55 0.55 0.56 0.57 0.57 0.57 0.59
Accounts Receivable Turnover
8.13 9.11 9.46 8.96 8.20 8.93 9.31 8.72 8.03 8.68 8.70
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
26.47 26.75 26.13 27.07 28.05 28.50 27.69 28.36 29.25 30.11 30.12
Accounts Payable Turnover
8.15 8.18 6.74 6.76 7.97 7.55 7.00 7.50 8.23 7.69 9.01
Days Sales Outstanding (DSO)
44.87 40.07 38.58 40.75 44.51 40.85 39.20 41.86 45.44 42.05 41.96
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
44.79 44.60 54.12 53.99 45.78 48.37 52.12 48.68 44.33 47.49 40.49
Cash Conversion Cycle (CCC)
0.09 -4.54 -15.54 -13.24 -1.27 -7.52 -12.92 -6.81 1.11 -5.44 1.47
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
3,093 2,836 2,825 3,031 3,282 3,263 3,241 3,285 3,253 3,159 3,147
Invested Capital Turnover
0.72 0.76 0.78 0.76 0.71 0.75 0.77 0.75 0.73 0.76 0.78
Increase / (Decrease) in Invested Capital
194 -26 13 186 188 427 416 253 -28 -104 -94
Enterprise Value (EV)
18,827 16,314 16,958 19,640 18,745 18,456 15,127 11,462 9,127 10,028 12,256
Market Capitalization
17,573 15,409 16,085 18,640 17,560 17,390 14,114 10,386 8,043 8,943 11,152
Book Value per Share
$47.31 $49.60 $50.28 $52.42 $54.09 $56.79 $57.83 $57.88 $57.39 $55.78 $56.29
Tangible Book Value per Share
($27.90) ($25.34) ($24.78) ($25.56) ($29.55) ($27.77) ($26.83) ($27.01) ($28.11) ($30.73) ($31.79)
Total Capital
3,506 3,318 3,278 3,351 3,529 3,585 3,555 3,537 3,498 3,422 3,372
Total Debt
1,704 1,428 1,366 1,359 1,472 1,430 1,368 1,369 1,369 1,390 1,370
Total Long-Term Debt
1,675 1,241 1,241 1,297 1,472 1,430 1,368 1,369 1,369 891 871
Net Debt
1,254 906 873 1,000 1,185 1,066 1,013 1,076 1,084 1,085 1,105
Capital Expenditures (CapEx)
22 21 26 26 24 25 34 31 26 30 27
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-58 -148 -199 -84 -61 -122 -147 -43 -67 -142 -204
Debt-free Net Working Capital (DFNWC)
392 374 294 275 226 242 208 250 218 162 62
Net Working Capital (NWC)
363 187 169 213 226 242 208 250 218 -337 -438
Net Nonoperating Expense (NNE)
11 9.90 8.20 9.68 11 12 -9.46 1.57 20 10 10
Net Nonoperating Obligations (NNO)
1,291 945 913 1,040 1,225 1,108 1,055 1,117 1,124 1,127 1,146
Total Depreciation and Amortization (D&A)
39 40 42 43 46 49 51 52 52 54 55
Debt-free, Cash-free Net Working Capital to Revenue
-2.69% -6.80% -9.03% -3.76% -2.72% -5.36% -6.32% -1.82% -2.79% -5.83% -8.22%
Debt-free Net Working Capital to Revenue
18.21% 17.18% 13.33% 12.34% 10.02% 10.56% 8.98% 10.58% 9.09% 6.64% 2.50%
Net Working Capital to Revenue
16.87% 8.58% 7.66% 9.53% 10.02% 10.56% 8.98% 10.58% 9.09% -13.83% -17.67%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$3.70 $4.15 $2.35 $3.95 $3.81 $3.92 $4.06 $4.08 $3.60 $3.51 $3.44
Adjusted Weighted Average Basic Shares Outstanding
38.10M 38.09M 38.06M 38.01M 38.02M 37.91M 37.92M 37.41M 36.93M 36.12M 36.47M
Adjusted Diluted Earnings per Share
$3.65 $4.09 $2.33 $3.89 $3.76 $3.87 $4.03 $4.06 $3.59 $3.50 $3.42
Adjusted Weighted Average Diluted Shares Outstanding
38.65M 38.64M 38.62M 38.52M 38.51M 38.34M 38.39M 37.62M 37.06M 36.19M 36.61M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
38.12M 38.04M 37.99M 38.03M 37.95M 37.81M 37.46M 37.10M 36.43M 35.57M 35.26M
Normalized Net Operating Profit after Tax (NOPAT)
152 168 100 160 156 160 144 154 153 137 131
Normalized NOPAT Margin
27.86% 30.43% 17.87% 28.08% 27.33% 27.37% 24.15% 25.37% 25.00% 21.95% 20.70%
Pre Tax Income Margin
30.89% 34.47% 20.83% 31.61% 30.20% 30.73% 31.66% 31.29% 26.37% 24.74% 22.75%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
10.99 12.01 8.28 13.29 13.36 12.80 15.50 15.12 13.27 12.09 10.93
NOPAT to Interest Expense
9.16 9.95 6.28 11.09 11.21 10.60 11.19 11.52 11.69 9.88 9.13
EBIT Less CapEx to Interest Expense
9.67 10.74 6.61 11.50 11.66 11.13 12.87 12.82 11.28 9.89 9.02
NOPAT Less CapEx to Interest Expense
7.84 8.68 4.61 9.29 9.50 8.93 8.55 9.21 9.70 7.68 7.22
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
29.69% 28.97% 28.05% 28.38% 28.63% 29.59% 26.79% 27.04% 27.82% 29.03% 30.78%
Augmented Payout Ratio
88.73% 83.87% 71.85% 69.99% 72.17% 77.85% 77.12% 92.35% 111.23% 137.28% 151.49%

Financials Breakdown Chart

Key Financial Trends

FactSet Research Systems (NYSE:FDS) continued to grow revenue through fiscal 2026, but profitability weakened as expenses and financing costs increased. Q4 2026 revenue reached $634.7 million, up 6.3% from $596.9 million in Q4 2025 and the highest quarterly level in the provided data. Revenue also rose sequentially from $607.6 million in Q1 to $634.7 million in Q4.

Despite the top-line growth, Q4 net income fell to $121.1 million from $153.6 million a year earlier. Operating income declined 11.7% year over year to $156.6 million, while diluted EPS fell from $4.03 to $3.42. FactSet’s gross margin declined to approximately 48.6% from 51.6%, and its operating margin fell to approximately 24.7% from 29.7%.

  • Revenue momentum remains intact: Q4 2026 revenue increased 6.3% year over year, and quarterly revenue rose steadily throughout fiscal 2026.
  • Operating cash flow remains strong: FactSet generated $204.7 million of operating cash flow in Q4 2026. Fiscal 2026 operating cash flow totaled approximately $822.2 million, up from roughly $726.3 million across the four reported quarters of fiscal 2025.
  • Share repurchases reduced the share count: Q4 diluted weighted-average shares declined to 36.6 million from 38.4 million a year earlier, a reduction of roughly 4.5%. This provides ongoing per-share support when earnings stabilize.
  • Dividend payments have increased: Quarterly dividends per share rose from $1.04 in fiscal 2025 to $1.10 in Q2 2026 and $1.16 in Q3 2026, indicating continued shareholder-return capacity.
  • Debt declined modestly from the prior-year comparison: At May 31, 2026, total debt was approximately $1.39 billion, compared with about $1.43 billion at May 31, 2025, despite continued capital returns.
  • Cash generation is being directed toward capital returns: In Q4 2026, FactSet repurchased $138.0 million of stock and paid $41.5 million in dividends. These actions may benefit shareholders but also contributed to a $54.8 million quarterly decline in cash and equivalents.
  • Liquidity is influenced by deferred revenue: Current assets totaled $727.5 million at May 31, 2026, compared with current liabilities of $1.06 billion. The apparent current-liability deficit is partly associated with deferred revenue and other operating liabilities, which are not equivalent to conventional debt.
  • Acquisition-related assets remain significant: Goodwill and intangible assets totaled approximately $3.15 billion at May 31, 2026, representing most of FactSet’s noncurrent assets. This supports the company’s acquired platform but increases exposure to future impairment charges.
  • Profitability has deteriorated despite revenue growth: Fiscal 2026 quarterly net income fell from $152.6 million in Q1 to $121.1 million in Q4, while operating income declined from $192.1 million to $156.6 million over the same period.
  • Higher costs and interest expense are pressuring earnings: Q4 operating costs and expenses increased to $478.1 million from $465.6 million a year earlier, while interest expense rose to $14.4 million from $12.9 million. Continued cost growth could limit the benefit of FactSet’s revenue expansion.

Overall, FactSet’s financial profile shows a durable recurring-revenue business with strong operating cash generation and aggressive shareholder returns. However, the recent pattern of rising revenue alongside falling margins and net income is a concern. Investors should watch whether the company can control operating costs, improve cash conversion and stabilize earnings before assuming that revenue growth will translate into stronger stock performance.

10/22/26 05:12 PM ETAI Generated. May Contain Errors.

FactSet Research Systems Financials - Frequently Asked Questions

According to the most recent income statement we have on file, FactSet Research Systems' financial year ends in August. Their financial year 2026 ended on August 31, 2026.

FactSet Research Systems' net income appears to be on an upward trend, with a most recent value of $533.48 million in 2026, rising from $338.82 million in 2016. The previous period was $597.04 million in 2025. Find out what analysts predict for FactSet Research Systems in the coming months.

FactSet Research Systems' total operating income in 2026 was $699.96 million, based on the following breakdown:
  • Total Gross Profit: $1.25 billion
  • Total Operating Expenses: $553.15 million

Over the last 10 years, FactSet Research Systems' total revenue changed from $1.13 billion in 2016 to $2.48 billion in 2026, a change of 119.7%.

In the past 11 quarters, FactSet Research Systems' cash and equivalents has ranged from $268.34 million in Q2 2026 to $453.14 million in Q3 2024, and is currently $288.11 million as of their latest financial filing in Q3 2026.

FactSet Research Systems had total debt of $1.37 billion at the end of 2026, a 0.1% increase from 2025, and a 356.7% increase since 2016.

Over the last 10 years, FactSet Research Systems' book value per share changed from 12.73 in 2016 to 56.29 in 2026, a change of 342.3%.



Financial statements for NYSE:FDS last updated on 10/20/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners